Literature DB >> 8051247

Cellular fatty acid composition and phenotypic and cultural characterization of CDC fermentative coryneform groups 3 and 5.

K Bernard1, M Bellefeuille, D G Hollis, M I Daneshvar, C W Moss.   

Abstract

Seventy strains of fermentative, asporogenous, gram-positive coccobacilli or short rods form two closely related groups which have been designated CDC fermentative coryneform groups 3 (32 strains, xylose fermenters) and 5 (38 strains, xylose nonfermenters). The two taxa are otherwise similar to each other phenotypically and culturally and by a distinctive Staphylococcus-like odor and by cellular fatty acid (CFA) composition. CDC group 3 and CDC group 5 strains have been isolated from clinical sources (blood, abscesses, and wounds but not urine or respiratory specimens) in Canada and the United States and among referrals from Belgium, Sweden, and Spain. Coryneform CDC group 3 strains were phenotypically similar to CDC coryneform group A-3 but were distinguishable by their inability to reduce nitrate and by their lack of motility. Coryneform CDC group 5 isolates were phenotypically somewhat similar to Actinomyces viscosus and Rothia dentocariosa, except that none of this group reduced nitrate. Both CDC groups could be differentiated from these similar bacteria by the ability to decarboxylate lysine and ornithine. The CFA compositions of CDC group 3 and 5 strains were similar to each other, were distinctive from those of other coryneforms, and were of the branched-chain type. API CORYNE codes were consistent for both CDC group 3 and CDC group 5 bacteria, suggesting that this method could be useful as an identification method.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051247      PMCID: PMC263650          DOI: 10.1128/jcm.32.5.1217-1222.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  2 in total

1.  Cultural and chemical characterization of CDC groups EO-2, M-5, and M-6, Moraxella (Moraxella) species, Oligella urethralis, Acinetobacter species, and Psychrobacter immobilis.

Authors:  C W Moss; P L Wallace; D G Hollis; R E Weaver
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

2.  Cellular fatty acid composition as an adjunct to the identification of asporogenous, aerobic gram-positive rods.

Authors:  K A Bernard; M Bellefeuille; E P Ewan
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

  2 in total
  7 in total

1.  Bacteremia by Dermabacter hominis, a rare pathogen.

Authors:  J L Gómez-Garcés; J Oteo; G García; B Aracil; J I Alós; G Funke
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

2.  Peritoneal dialysis-associated peritonitis caused by Dermabacter hominis.

Authors:  A Radtke; K Bergh; C M Øien; L S Bevanger
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

Review 3.  Clinical microbiology of coryneform bacteria.

Authors:  G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

4.  Rothia dentocariosa septicemia without endocarditis in a neonatal infant with meconium aspiration syndrome.

Authors:  Jeong Hwan Shin; Jae Dong Shim; Hye Ran Kim; Jong Beom Sinn; Joong-Ki Kook; Jeong Nyeo Lee
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

5.  Multiply methyl-branched fatty acids and diacids in the polar lipids of a microaerophilic subsurface microbial community.

Authors:  David B Hedrick; Aaron D Peacock; Philip Long; David C White
Journal:  Lipids       Date:  2008-07-09       Impact factor: 1.880

Review 6.  Cerebral Dermabacter hominis abscess.

Authors:  M Bavbek; H Caner; H Arslan; B Demirhan; S Tunçbilek; N Altinörs
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

7.  Recognition of Dermabacter hominis, formerly CDC fermentative coryneform group 3 and group 5, as a potential human pathogen.

Authors:  E Gruner; A G Steigerwalt; D G Hollis; R S Weyant; R E Weaver; C W Moss; M Daneshvar; D J Brenner
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.